DIANTHUS THERAPEUTICS & DESIGN

View On IC.GC.CA

FORMALIZED

on 1 Nov 2022

Last Applicant/ Owned by

DIANTHUS THERAPEUTICS OPCO INC.

204 Crescent StreetBuilding 4, Suite 205Waltham, MA 02453

Serial Number

2219278 filed on 1^st Nov 2022

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO

ONTARIO

M5H2T6

DIANTHUS THERAPEUTICS & DESIGN

Trademark usage description

monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases research and development services for the developmen Read More

Vienna Information

16 . 3 . 1

Photographic or cinematographic apparatus, projection apparatus and lanterns -- Note: Including video cameras, traffic radars and photographic lenses.Appareils photographiques ou cinématographiques, appareils et lanternes de projection -- Note: Y compris les caméras vidéo, les radars routiers et les objectifs photographiques.

16 . 3 . 3

Iris diaphragmsDiaphragmes en forme d'iris

Classification Information

Class [001]
Monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases

Classification kind code

Class [005]
Pharmaceuticals and herbicides

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Research and development services for the development of monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases; clinical trials for others involving monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases

Classification kind code

Mark Details

Serial Number

2219278

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 135 on 30^th Apr 2024	Amendment to Application
Submitted for opposition 287 on 10^th Nov 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 1^st Nov 2022	Filed
Submitted for opposition 1 on 1^st Nov 2022	Created
Submitted for opposition 31 on 1^st Nov 2022	Formalized

DIANTHUS THERAPEUTICS & DESIGN

Classification Information

Class [001]Monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases

Classification kind code

Class [005]Pharmaceuticals and herbicides

Comment text

Classification kind code

Class [042]Research and development services for the development of monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases; clinical trials for others involving monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [001]
Monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases

Class [005]
Pharmaceuticals and herbicides

Class [042]
Research and development services for the development of monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases; clinical trials for others involving monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases